Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-032602
Filing Date
2014-09-25
Accepted
2014-09-25 15:52:34
Documents
1
Period of Report
2014-09-23

Document Format Files

Seq Description Document Type Size
1 ANNUAL DIRECTOR GRANT rrd416626.html 4  
1 ANNUAL DIRECTOR GRANT rrd416626.xml 4 3762
  Complete submission text file 0001181431-14-032602.txt   5305
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6701 KAISER DRIVE FREMONT CA 94555
Business Address
GREER R SCOTT (Reporting) CIK: 0001211703 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 141120659